Transcranial Magnetic Stimulation

Similar documents
Introduction to TMS Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation for the Treatment of Depression

Exciting links: imaging and modulation of neural networks underlying key symptoms of schizophrenia Bais, Leonie

The first modern transcranial magnetic stimulation

Transcranial Magnetic Stimulation

Statement on Repetitive Transcranial Magnetic Stimulation for Depression. Position statement CERT03/17

Brian A. Coffman, PhD

APPLICATIONS OF ASL IN NEUROSCIENCE

Is There Evidence for Effectiveness of Transcranial Magnetic Stimulation in the Treatment of Psychiatric Disorders?

Original Effective Date: 8/28/2013. Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression

Repetitive transcranial magnetic stimulation for depression

Use of Repetitive Transcranial Magnetic Stimulation for Treatment in Psychiatry

Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes

Transcranial Magnetic Stimulation

L'application de la TMS dans l'étude des fonctions cognitives

Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: A comprehensive review

Todd Hutton, M.D. Karl Lanocha, M.D Richard Bermudes, M.D. Kimberly Cress, M.D.

Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders

Neurophysiological Basis of TMS Workshop

Case Report Transcranial Magnetic Stimulation for the Treatment of Pharmacoresistant Nondelusional Auditory Verbal Hallucinations in Dementia

Seeing through the tongue: cross-modal plasticity in the congenitally blind

Copyright 2002 American Academy of Neurology. Volume 58(8) 23 April 2002 pp

LEASE DO NOT COPY. Neurological Applications of Transcranial Magnetic Stimulation

Recovery mechanisms from aphasia

TRANSCRANIAL MAGNETIC STIMULATION

University of Groningen. Negative symptoms of schizophrenia de Lange, Jozarni

Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders

Use of transcranial direct current stimulation for the treatment of auditory hallucinations of schizophrenia a systematic review

Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study

Treatment of Depression: A Brief History

Intraoperative Monitoring: Role in Epilepsy Based Tumor Surgery December 2, 2012

Repetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders

Transcranial Direct-Current Stimulation

Auditory verbal hallucinations predominantly activate the right inferior frontal area

Transcranial Magnetic Stimulation:

Transcranial Magnetic Stimulation (TMS) as a treatment tool in schizophrenia: A review.

Review Paper. Introduction

Non-therapeutic and investigational uses of non-invasive brain stimulation

Repetitive Transcranial Magnetic Stimulation (rtms)

UCLA%Principles%of%Neuroimaging

Case 2:15-cv MWF-JPR Document Filed 03/20/17 Page 1 of 36 Page ID #:388 EXHIBIT 1

HCT Medical Policy. Transcranial Magnetic Stimulation (TMS) for Major Depression Policy # 121 Current Effective Date: 05/24/2016.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

CEREBRUM. Dr. Jamila EL Medany

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Neurosoft TMS. Transcranial Magnetic Stimulator DIAGNOSTICS REHABILITATION TREATMENT STIMULATION. of motor disorders after the stroke

TREATMENT-SPECIFIC ABNORMAL SYNAPTIC PLASTICITY IN EARLY PARKINSON S DISEASE

Effect of Transcranial Magnetic Stimulation(TMS) on Visual Search Task

Interventions for Relapsing Depression: TMS, ECT, and Ketamine

University of Groningen. Negative symptoms of schizophrenia de Lange, Jozarni

Interventions for Relapsing Depression: TMS, ECT, and Ketamine

PSYC& 100: Biological Psychology (Lilienfeld Chap 3) 1

TMS: Full Board or Expedited?

Summary of my talk. Cerebellum means little brain but a huge neural resource. Studying the cerebellum in. Chris Miall

fmri guided orbitofrontal cortical repetitive transcranial magnetic stimulation in treatment resistant OCD: a randomized, sham-controlled trial

Effects of Sub-Motor-Threshold Transcranial Magnetic Stimulation on. Event-Related Potentials and Motor-Evoked Potentials

Acetylcholine (ACh) Action potential. Agonists. Drugs that enhance the actions of neurotransmitters.

Where Neuromodulation and Neuropsychology Meet: Promoting Plasticity for Brain Health

By Lauren Stowe, PhD, CCC-SLP & Gina Rotondo, MS, CCC-SLP The Speech Therapy Group

Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders Corporate Medical Policy

Iris Else Sommer Selected references

Title:Atypical language organization in temporal lobe epilepsy revealed by a passive semantic paradigm

MagPro by MagVenture. Versatility in Magnetic Stimulation

What is Repetitive Transcranial Magnetic Stimulation?

Effects of Short-Term Repetitive Transcranial Magnetic Stimulation on P300 Latency in an Auditory Odd-Ball Task

MagPro by MagVenture. Versatility in Magnetic Stimulation

Transcranial Magnetic Stimulation in the investigation and treatment of schizophrenia: a review

Supplemental Information. Triangulating the Neural, Psychological, and Economic Bases of Guilt Aversion

PsychoBrain. 31 st January Dr Christos Pliatsikas. Lecturer in Psycholinguistics in Bi-/Multilinguals University of Reading

Quick review of neural excitability. Resting Membrane Potential. BRAIN POWER: non-invasive brain stimulation in neurorehabilitation

The neurolinguistic toolbox Jonathan R. Brennan. Introduction to Neurolinguistics, LSA2017 1

Define functional MRI. Briefly describe fmri image acquisition. Discuss relative functional neuroanatomy. Review clinical applications.

Supplementary materials

Theory of mind skills are related to gray matter volume in the ventromedial prefrontal cortex in schizophrenia

Homework Week 2. PreLab 2 HW #2 Synapses (Page 1 in the HW Section)

Administration of repetitive transcranial magnetic stimulation (rtms)

Therapeutic Uses of Noninvasive Brain Stimulation Current & Developing

Update on Repetitive Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Different Targets

BME 701 Examples of Biomedical Instrumentation. Hubert de Bruin Ph D, P Eng

Modules 4 & 6. The Biology of Mind

AdvAnced TMS. Research with PowerMAG Products and Application Booklet

Magnetic and Electrical Stimulation in the Treatment of Aphasia

Exam 1 PSYC Fall 1998

Supplementary Material S3 Further Seed Regions

Transcranial magnetic stimulation for the treatment of major depression

Investigations in Resting State Connectivity. Overview

Water immersion modulates sensory and motor cortical excitability

Neural Communication. Central Nervous System Peripheral Nervous System. Communication in the Nervous System. 4 Common Components of a Neuron

BRAINSWAY DEEP TMS SYSTEM

1. Processes nutrients and provides energy for the neuron to function; contains the cell's nucleus; also called the soma.

Nervous System, Neuroanatomy, Neurotransmitters

Transcranial magnetic stimulation has become an increasingly

Brain and Cognition. Cognitive Neuroscience. If the brain were simple enough to understand, we would be too stupid to understand it

3/1/18. Overview of the Talk. Important Aspects of Neuroimaging Technology

Social Cognition and the Mirror Neuron System of the Brain

NEURO-MS TMS. Diagnostic Monophasic Magnetic Stimulator

Neuromodulation Approaches to Treatment Resistant Depression

Transcranial direct current stimulation modulates shifts in global/local attention

Transcranial Magnetic Stimulation: Scientific Underpinnings and Practical Applications

Transcranial Magnetic Stimulaton: In-Depth Review of Methods, Efficacy and Future Applications

Transcription:

Transcranial Magnetic Stimulation Scientific evidence in major depression and schizophrenia C.W. Slotema Parnassia Bavo Group The Hague, the Netherlands

Faraday s law (1831) Electrical current magnetic field D Arsonval 1896 head in magnetic field phosphenes, vertigo and syncope 1985 Anthony Barker first TMS-device

One flow pulse TMS Duration 1/4000 s Peakage voltage 2000 V Amount of electric charge 10.000 A Magnetic field 1,5-2,5 Tesla

Magnetic field rapid decline Range 2 (to 4) cm Effect on greater distance

Single pulse TMS Paired pulse TMS Repetitive TMS High-frequency 5Hz MEP Low-frequency 1Hz MEP

Effect Depolarization of neurons Effect longer than stimuli Long term depression / potentiation Change neurotransmitter level (NMDA, dopamine)

TMS indications Brain mapping Measuring cortical excitability Investigation of neural networks/connectivity Influence of brain functions

Variables of TMS Focus Type of coil Frequency Motor threshold Number of stimuli Number of sessions

TMS as treatment Major depressive disorder Negative symptoms Auditory verbal hallucinations

rtms for major depressive disorder Baxter 1989 left anterior hypoactivity in depressive patients (recovery balance left and right prefrontal cortex) George 1995 high-frequency rtms L DLPF 2008 FDA approval

Meta-analysis rtms for depression Slotema et al. J Clin Psych 2010 Total hg = 0.55 p 0.001 L DLPF hg = 0.53 p 0.001 R DLPF hg = 0.82 p 0.001 LR DLPF hg = 0.47 p = 0.03 Monotherapy hg = 0.96 p 0.001 Addition to AD hg = 0.51 p 0.001 Simultaneous onset AD hg = 0.37 p = 0.03 No psychosis vs t = 0.128 p = 0.04 Antidepressive agents hg = 0.17-0.46 (Moncrieff 2004, Joffe 1996) Psychotherapy d= 0.42 (Cuijpers 2010)

Variables Focus Type of coil Frequency Motor threshold Number of stimuli Number of sessions

Literature other rtms paradigms for depression Focus Parietal cortex 2Hz partial response (Schutter et al. 2009) Coil H coil, n = 65 open label, positive on depression and cogn functioning (Levkovitz 2009) Frequency Priming better than sham (Fitzgerald 2008) Theta burst open label (Chistyakov 2010)

rtms for negative symptoms of schizophrenia Activity & metabolism prefrontal cortex cognitive dysfunction in schizophrenia (Hill 2004 & Andreasen 1997) Low-frequency rtms R DLPF (Klein 1999)

rtms for negative symptoms

rtms for negative symptoms of schizophrenia d= 0.43; 95% CI, 0.05-0.80 (Dlabac-de Lange 2010) d = 0.39, p = 0.12 (Slotema 2010) d = 0.27, p = 0.42 (Freitas 2009) Antipsychotics 0.17-0.21 (Leucht 1999)

Variables Focus Type of coil Frequency Motor threshold Number of stimuli Number of sessions

Other paradigms for negative symptoms of schizophrenia Deep brain TMS 20 Hz prefrontal cx open label improvement of cognitive functioning and negative symptoms in 15 pts (Levkovitz 2011) Thetaburst TMS cerebellar vermis 8 pts open label decline of negative symptoms no change of positive symptoms (Demirtes- Tatlidede 2010)

rtms for auditory hallucinations rtms 1 hertz, 90%MT Left temporoparietal area (Hoffman 1999) Hyperactivity L TP (Silbersweig 1995, Shergill 2000)

Effect sizes 6 meta-analyses rtms for AVH 0.76 Aleman 2007 0.51 Tranulis 2008 1.0 Freitas 2009 0.54 Slotema 2010 0.42 Demeulemeester 2012 0.44 Slotema in press

RCT rtms for AVH Study Focus Frequency MT% Stimuli Sessions Blumberger L prim aud cx 1 115 1200 20 L prim aud cx priming 90 115 4200 20 Jesus 2010 T3P3 1 80 1200 20 Slotema 2011 T3P3 1 90 1200 20 fmri 1 90 1200 20 Vercammen 2009 T3P3 1 90 1200 12 T3P3 T4P4 1 90 1200 12 Rosa 2007 T3P3 1 90 960 10 Brunelin 2006 T3P3 1 90 1000 10 Chibbaro 2005 T3P3 1 90 900 4 Fitzgerald 2005 T3P3 1 90 900 10 Hoffman 2005 T3P3 1 90 900 10 Lee 2005 T3P3 1 100 1600 10 T4P4 1 100 1600 10 Saba 2004 T3P3 1 80 300 10

Meta-analysis left temporoparietal cortex Slotema et al. in press Schizophr Res Study name Subgroup within study Hedges's g and 95% CI Hedges's g p-value Slotema b T3P3 0,000 1,000 Brunelin T3P3 1,158 0,008 Vercammen b T3P3-0,175 0,613 de Jesus T3P3 0,464 0,321 Hoffman T3P3 0,552 0,052 Rosa PANSS pos T3P3-0,084 0,880 Chibbaro SAH T3P3 1,283 0,014 Saba PANSS pos T3P3-0,053 0,910 Lee b frequency T3P3 0,498 0,189 Fitzgerald HCS T3P3 0,329 0,344 Jandl c PSYRATS T3P3 0,534 0,154 Loo c T3P3 0,034 0,916 Poulet c T3P3 1,350 0,005 McIntoshc PANSS pos T3P3 0,195 0,573 Hoffman c hcs T3P3 1,219 0,005 0,437 0,000-2,00-1,00 0,00 1,00 2,00 sham rtms Meta Analysis

Low-frequency rtms at the L temporoparietal cortex for auditory verbal hallucinations

Meta-analysis rtms left temporoparietal area: effect after one month Slotema et al. in press Schizophrenia Res Study name Subgroup within study Hedges's g and 95% CI Hedges's g p-value de Jesus T3P3 0,359 0,441 Rosa frequency T3P3 0,770 0,182 Slotema b T3P3 0,018 0,953 Bais b T3P3-0,327 0,346 Chibbaro T3P3 1,713 0,002 0,396 0,215-2,00-1,00 0,00 1,00 2,00 sham rtms

Variables Focus Type of coil Frequency Motor threshold Number of stimuli Number of sessions

Focus of rtms for AVH + T3P3 TP cortex & L supramarginal gyrus T4P4 1 RCT (+), 1 RCT (-) T4P4 & T3P3 (-) - Broca s area or homologue Primary auditory cortex or homologue L superior temporal gyrus fmri-targeted L primary auditory cortex Area with maximal hallucinatory activation fmri

fmri during AVH > 50% hallucinatory activation in the right hemisphere! Sommer et al. Brain 2008

Neural Nagivator Neggers et al. Neuroimage 2004

Figuur AHRS total score Slotema et al. Biol Psych 2011

Coil Deep brain TMS LTP RCT sham no differences, 18pts, dropouts 8 (Rosenberg 2012) LTP, open label (n = 8) (Rosenberg 2011)

Frequency 1 Hz Priming TMS (n = 23, RCT) Slotema et al. Accepted Brain Stimulation 20 Hz (open label, n = 11, 2 days, L sup temp sulcus) (Montagne-Larmurier 2009) 50 Hz case reports

Motor threshold & total number of stimuli No studies MT 100% LTP Blumberger 115% no effect primary auditory cortex Total number of stimuli til maximum of 24,000 High vs low number of stimuli no better effect

Discussion Sham condition Therapy resistance in majority of participants Studies were underpowered? Neuroimaging guidance (Herwig 2001) Duration of effect weeks? Other treatment paradigms have not been (fully) investigated until now

Conclusions rtms for major depressive disorder TMS for major depressive disorder Many RCT s Moderate mean weighted effect size Monotherapy? No psychosis Low-frequency R DLPF?

Conclusions rtms for schizophrenia TMS for auditory hallucinations Small number of studies Decreasing, moderate mean weighted effect size Duration effect might be less than 1 month TMS for negative symptoms Small number of studies Promising as other treatment options are poor

Conclusions, side effects Mild High-frequency more than lowfrequency Frontal labe more than temporal lobe

Main issue: does rtms work? Is there a future for therapeutic use of transcranial magnetic stimulation (Ridding and Rothwell Nature 2007) Duration after-effects: 30-60 min 5 to 6 times more current needed to stimulate language areas versus motor cortex (Pouratian 2004 J Neurosurg, Lesser 1987 J Clin Neurophysiol, Lesser 1984 Epilepsia)

Future directions Working mechanism of rtms Other paradigms of rtms